FDA Drug Recalls

Recalls / Class III

Class IIID-1609-2014

Product

Olanzapine Orally Disintegrating Tablets 5 mg, 30-count Bottle, Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada M9L1T9, Manufactured for Apotex Corp., Weston, Florida 33326, NDC # 60505-3275-03

Affected lot / code info
Lot # KM4951; Exp. 04/15

Why it was recalled

Subpotent Drug: Out of specification (OOS) results at the 9 month temperature point.

Recalling firm

Firm
Apotex Corp.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2400 N Commerce Pkwy Ste 400, N/A, Weston, Florida 33326-3253

Distribution

Quantity
5,397 bottles
Distribution pattern
Nationwide.

Timeline

Recall initiated
2014-04-18
FDA classified
2014-09-24
Posted by FDA
2014-10-01
Terminated
2017-04-07
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1609-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.